Inventor · disambiguated record
Pierre Lemieux
Also filed as: LEMIEUX PIERRE · LEMIEUX PIERRE M
7 granted patents·11 pending applications·168 citations·filing 1998–2021
84Inventor score
Files withACASTI PHARMA INC3SIMARD ERIC3SUPRATEK PHARMA INC3TECHNOLOGIES BIOLACTIS INC3AKER BIOMARINE HUMAN INGREDIENTS AS1
Top patents by PatentIndex Score
18 records- 0185US8088605B2Exopolysaccharides delivery system for active moleculesBEAUDET NICOLAS·Filed 2003·Granted Jan 3, 2012·53 cites·32 claims
- 0284US6359054B1Polynucleotide compositions for intramuscular administrationSUPRATEK PHARMA INC·Filed 1999·Granted Mar 19, 2002·77 cites·25 claims
- 0371US6656459B2Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereofSUPRATEK PHARMA INC·Filed 2001·Granted Dec 2, 2003·7 cites·15 claims
- 0464US6232340B1Vanadium complexes and derivatives thereof and methods related theretoANGIOTECH PHARM INC·Filed 1998·Granted May 15, 2001·28 cites·47 claims
- 0555US7256180B2Compositions and methods for inducing activation of dendritic cellsSUPRATEK PHARMA INC·Filed 2001·Granted Aug 14, 2007·3 cites·12 claims
- 0652US2006051354A1Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereofSIMARD ERIC·Filed 2003·Application pending·0 cites
- 0748US2003191081A1Pharmaceutical compositions and methods of use thereof comprising polyanionic polymers and amphiphilic block copolymers to improve gene expressionFiled 2002·Application pending·0 cites
- 0847US2023024058A1Composition that promote pro-resolving mediatorsACASTI PHARMA INC·Filed 2021·Application pending·0 cites
- 0946US2010272676A1Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereofTECHNOLOGIES BIOLACTIS INC·Filed 2010·Application pending·0 cites
- 1045US2009130072A1Use of Lactobacillus Kefiranofaciens as a Probiotic and a SynbioticLEMIEUX PIERRE·Filed 2006·Application pending·0 cites
- 1145US2011002994A1Method of regulating the th17 pathway and its associated metabolic impactINST NAT RECH SCIENT·Filed 2008·Application pending·0 cites
- 1244US2014193383A1Use of lactobacillus kefiranofaciens as a probiotic and a synbioticTECHNOLOGIES BIOLACTIS INC·Filed 2013·Application pending·0 cites
- 1344US2014328878A1Malleable protein matrix and uses thereofTECHNOLOGIES BIOLACTIS INC·Filed 2014·Application pending·0 cites
- 1442US11326922B2Apparatus for metering and dispensing viscous substanceACASTI PHARMA INC·Filed 2019·Granted May 10, 2022·0 cites·20 claims
- 1541US2006057131A1Malleable protein matrix and uses thereofSIMARD ERIC·Filed 2002·Application pending·0 cites
- 1639US2013029906A1Method of regulating ppar, obesity related pathways and their associated metabolic impactSIMARD ERIC·Filed 2010·Application pending·0 cites
- 1737US12194064B2Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acidsAKER BIOMARINE HUMAN INGREDIENTS AS·Filed 2020·Granted Jan 14, 2025·0 cites·19 claims
- 1833US2021077539A1Process for the manufacture of enriched phospholipid compositionsACASTI PHARMA INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →